Trial Details

Not Available
Basic Information
Clinical ID c2926
Identifier EUCTR2016-000522-18-FR
Trial Title Risk stratified randomized controlled trial in paediatric Crohn Disease: Methotrexate versus azathioprine or adalimumab for maintaining remission in patients at low or at high risk for aggressive disease course, respectively a treatment strategy - REDUCE-RISKincd-PIBD-TRIAL
Trial URL Visit Original Page
Study Information
Study Results

No results available
Conditions Crohn disease;Therapeutic area: Diseases [C] - Digestive System Diseases [C06]
Interventions Product Name: humira Pharmaceutical Form: Solution for infusion INN or Proposed INN: ADALIMUMAB CAS Number: 331731-18-1 Concentration unit: mg milligram(s) Concentration type: equal Concentration number: 160- Product Name: Imurel Pharmaceutical Form: Coated tablet INN or Proposed INN: azathioprine CAS Number: 446-86-6 Other descriptive name: AZATHIOPRINE Concentration unit: mg/kg milligram(s)/kilogram Concentration type: equal Concentration number: 2.5- Trade Name: Methotrexate Product Name: methotrexate Pharmaceutical Form: Solution for injection
Participant Information
Sponsor PIBDNet
City -
Country/Region France;Hungary;Czech Republic;Canada;Poland;Belgium;Israel;Netherlands;Germany;Italy;United Kingdom
Enrollment Criteria
Sex Requirement NOT SPECIFIED
Age Requirement -
Study Design
Study Type Interventional clinical trial of medicinal product
Phase PHASE4
Time Information
Start Date 2025-04-24
Primary Completion Date -
Completion Date -